Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhGH and PRP in Treatment-Resistant Knee and Ankle Osteoarthritis
NCT06907121Phase 3Not yet recruiting
- Sponsor
- Integrant
- Start
- Nov 2026
- Primary completion
- Aug 2027
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin, platelet-rich plasma in osteoarthritis (OA), sponsored by Integrant. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
somatropinplatelet-rich plasma
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06907121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06907121.